372 related articles for article (PubMed ID: 33515777)
1. Preventing or controlling periodontitis reduces the occurrence of osteonecrosis of the jaw (ONJ) in rice rats (Oryzomys palustris).
Castillo EJ; Messer JG; Abraham AM; Jiron JM; Alekseyenko AV; Israel R; Thomas S; Gonzalez-Perez GM; Croft S; Gohel A; Bhattacharyya I; Yarrow JF; Novince CM; Kimmel DB; Aguirre JI
Bone; 2021 Apr; 145():115866. PubMed ID: 33515777
[TBL] [Abstract][Full Text] [Related]
2. Anti-vascular endothelial growth factor antibody monotherapy causes destructive advanced periodontitis in rice rats (Oryzomys palustris).
Messer JG; Castillo EJ; Abraham AM; Jiron JM; Israel R; Yarrow JF; Thomas S; Reynolds MC; Wnek RD; Jorgensen M; Wanionok N; Van Poznak C; Bhattacharyya I; Kimmel DB; Aguirre JI
Bone; 2020 Jan; 130():115141. PubMed ID: 31707108
[TBL] [Abstract][Full Text] [Related]
3. Zoledronic acid increases the prevalence of medication-related osteonecrosis of the jaw in a dose dependent manner in rice rats (Oryzomys palustris) with localized periodontitis.
Messer JG; Mendieta Calle JL; Jiron JM; Castillo EJ; Van Poznak C; Bhattacharyya N; Kimmel DB; Aguirre JI
Bone; 2018 Mar; 108():79-88. PubMed ID: 29289789
[TBL] [Abstract][Full Text] [Related]
4. Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis.
Aguirre JI; Akhter MP; Kimmel DB; Pingel JE; Williams A; Jorgensen M; Kesavalu L; Wronski TJ
J Bone Miner Res; 2012 Oct; 27(10):2130-43. PubMed ID: 22623376
[TBL] [Abstract][Full Text] [Related]
5. Zoledronate treatment duration is linked to bisphosphonate-related osteonecrosis of the jaw prevalence in rice rats with generalized periodontitis.
Messer JG; Jiron JM; Mendieta Calle JL; Castillo EJ; Israel R; Phillips EG; Yarrow JF; Van Poznak C; Kesavalu L; Kimmel DB; Aguirre JI
Oral Dis; 2019 May; 25(4):1116-1135. PubMed ID: 30712276
[TBL] [Abstract][Full Text] [Related]
6. Osteonecrosis of the Jaw Developed in Mice: DISEASE VARIANTS REGULATED BY γδ T CELLS IN ORAL MUCOSAL BARRIER IMMUNITY.
Park S; Kanayama K; Kaur K; Tseng HC; Banankhah S; Quje DT; Sayre JW; Jewett A; Nishimura I
J Biol Chem; 2015 Jul; 290(28):17349-66. PubMed ID: 26013832
[TBL] [Abstract][Full Text] [Related]
7. Intermittent parathyroid hormone enhances the healing of medication-related osteonecrosis of the jaw lesions in rice rats.
Castillo EJ; Jiron JM; Croft CS; Freehill DG; Castillo CM; Kura J; Yarrow JF; Bhattacharyya I; Kimmel DB; Aguirre JI
Front Med (Lausanne); 2023; 10():1179350. PubMed ID: 37404809
[TBL] [Abstract][Full Text] [Related]
8. The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program.
Grbic JT; Black DM; Lyles KW; Reid DM; Orwoll E; McClung M; Bucci-Rechtweg C; Su G
J Am Dent Assoc; 2010 Nov; 141(11):1365-70. PubMed ID: 21037195
[TBL] [Abstract][Full Text] [Related]
9. Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results.
Jackson GH; Morgan GJ; Davies FE; Wu P; Gregory WM; Bell SE; Szubert AJ; Navarro Coy N; Drayson MT; Owen RG; Feyler S; Ashcroft AJ; Ross FM; Byrne J; Roddie H; Rudin C; Boyd KD; Osborne WL; Cook G; Child JA
Br J Haematol; 2014 Jul; 166(1):109-17. PubMed ID: 24673708
[TBL] [Abstract][Full Text] [Related]
10. Osteonecrosis of the jaw in patients with cancer who received zoledronic acid and bevacizumab.
Francini F; Pascucci A; Francini E; Miano ST; Bargagli G; Ruggiero G; Petrioli R
J Am Dent Assoc; 2011 May; 142(5):506-13. PubMed ID: 21531932
[TBL] [Abstract][Full Text] [Related]
11. Removal of Pre-Existing Periodontal Inflammatory Condition before Tooth Extraction Ameliorates Medication-Related Osteonecrosis of the Jaw-Like Lesion in Mice.
Kim T; Kim S; Song M; Lee C; Yagita H; Williams DW; Sung EC; Hong C; Shin KH; Kang MK; Park NH; Kim RH
Am J Pathol; 2018 Oct; 188(10):2318-2327. PubMed ID: 30059656
[TBL] [Abstract][Full Text] [Related]
12. Chronic Periodontal Infection and Not Iatrogenic Interference Is the Trigger of Medication-Related Osteonecrosis of the Jaw: Insights from a Large Animal Study (PerioBRONJ Pig Model).
Troeltzsch M; Zeiter S; Arens D; Nehrbass D; Probst FA; Liokatis P; Ehrenfeld M; Otto S
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241232
[No Abstract] [Full Text] [Related]
13. Zoledronate induces osteonecrosis of the jaw in sheep.
Voss PJ; Stoddart M; Ziebart T; Zeiter S; Nelson K; Bittermann G; Schmelzeisen R; Poxleitner P
J Craniomaxillofac Surg; 2015 Sep; 43(7):1133-8. PubMed ID: 26154396
[TBL] [Abstract][Full Text] [Related]
14. Clinically Relevant Doses of Sclerostin Antibody Do Not Induce Osteonecrosis of the Jaw (ONJ) in Rats with Experimental Periodontitis.
Hadaya D; Gkouveris I; Soundia A; Bezouglaia O; Boyce RW; Stolina M; Dwyer D; Dry SM; Pirih FQ; Aghaloo TL; Tetradis S
J Bone Miner Res; 2019 Jan; 34(1):171-181. PubMed ID: 30184271
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial photodynamic therapy improves the alveolar repair process and prevents the occurrence of osteonecrosis of the jaws after tooth extraction in senile rats treated with zoledronate.
Ervolino E; Statkievicz C; Toro LF; de Mello-Neto JM; Cavazana TP; Issa JPM; Dornelles RCM; de Almeida JM; Nagata MJH; Okamoto R; Casatti CA; Garcia VG; Theodoro LH
Bone; 2019 Mar; 120():101-113. PubMed ID: 30339908
[TBL] [Abstract][Full Text] [Related]
16. Diminished Progression of Periapical Lesions with Zoledronic Acid in Ovariectomized Rats.
Wayama MT; Yoshimura H; Ohba S; Yoshida H; Matsuda S; Kobayashi J; Kobayashi M; Gomes Filho JE; Sano K
J Endod; 2015 Dec; 41(12):2002-7. PubMed ID: 26490005
[TBL] [Abstract][Full Text] [Related]
17. [Bisphosphonate and osteonecrosis of the jaw.].
Taguchi A
Clin Calcium; 2017; 27(2):225-231. PubMed ID: 28123124
[TBL] [Abstract][Full Text] [Related]
18. Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan.
Ripamonti CI; Maniezzo M; Campa T; Fagnoni E; Brunelli C; Saibene G; Bareggi C; Ascani L; Cislaghi E
Ann Oncol; 2009 Jan; 20(1):137-45. PubMed ID: 18647964
[TBL] [Abstract][Full Text] [Related]
19. Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancer.
Coleman R; Woodward E; Brown J; Cameron D; Bell R; Dodwell D; Keane M; Gil M; Davies C; Burkinshaw R; Houston SJ; Grieve RJ; Barrett-Lee PJ; Thorpe H
Breast Cancer Res Treat; 2011 Jun; 127(2):429-38. PubMed ID: 21394500
[TBL] [Abstract][Full Text] [Related]
20. The association between the severity of periodontitis and osteonecrosis of the jaw in patients with different cancer locations: a nationwide population-based study.
Huang YF; Lin KC; Liu SP; Chang CT; Muo CH; Chang PJ; Tsai CH; Wu CZ
Clin Oral Investig; 2022 May; 26(5):3843-3852. PubMed ID: 35482084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
